No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 16.2x · 10Y median 24.3x · 31st percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 23
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T15:57:29.725Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Nexalin Technology, Inc. (NXL) stock was $4.79 as of Oct 6, 2026, 11:53 AM EDT, down 11.79% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -80.0% · 3-year avg -22.6%/yr
Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China.
Medical - Devices · Houston, TX
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 13, 2026
38 days away
EPS Estimate
-2.91
Revenue Est.
$75000.00
Last Quarter Results
EPS
$-3.30
vs Estimate
$-3.00
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1NXL | $3.51M | $4.79 | -11.79% | -79.96% | N/A | N/A | N/A |
| 2EVGN | $3.52M | $0.41 | +1.16% | -64.71% | -56.46% | -39.70% | vs NXL |
| 3MBIO | $3.49M | $0.46 | +0.22% | -70.71% | -80.80% | N/A | vs NXL |
| 4EOCN | $3.46M | $3.32 | -3.85% | N/A | N/A | N/A | vs NXL |
| 5CVKD | $3.41M | $0.96 | +1.18% | -93.24% | N/A | N/A | vs NXL |
| 6MLEC | $3.39M | $4.67 | -3.86% | -64.99% | -68.13% | N/A | vs NXL |
forward FY estimate
N/A
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$12000.00
vs Estimate
$90000.00
Consensus Rating
Based on 1 analyst
Average Price Target
$15.00
+213.2% upside
Low
$15.00
Current
$4.79
High
$15.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-2.91 | $-2.91 | $-2.91 | 1 |
| Quarter ending Dec 2026 | $-2.34 | $-2.34 | $-2.34 | 1 |
| Quarter ending Mar 2027 | $-2.22 | $-2.22 | $-2.22 | 1 |
| Quarter ending Jun 2027 | $-2.13 | $-2.13 | $-2.13 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-11.42 | $-11.42 | $-11.42 | 1 |
| FY 2027 | $-7.55 | $-7.55 | $-7.55 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $75000.00 | $75000.00 | $75000.00 | 1 |
| Quarter ending Dec 2026 | $90000.00 | $90000.00 | $90000.00 | 1 |
| Quarter ending Mar 2027 | $45000.00 | $45000.00 | $45000.00 | 1 |
| Quarter ending Jun 2027 | $45000.00 | $45000.00 | $45000.00 | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $192000.00 | $192000.00 | $192000.00 | 1 |
| FY 2027 | $338000.00 | $338000.00 | $338000.00 | 1 |
